We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current QNRX market cap is 2.28M. The company's latest EPS is USD and P/E is N/A.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| ILS (ILS) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -2.26M | -2.13M | -2.22M | -2.46M | -2.14M |
| Net Income | -2.11M | -1.93M | -2.05M | -2.33M | -1.97M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| ILS (ILS) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -22.33M | -1.67M | -6.06M | -9.26M | -9.38M |
| Net Income | -16.81M | -2.1M | -21.46M | -9.45M | -8.69M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| ILS (ILS) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 16.71M | 15.07M | 12.17M | 16.12M | 14.06M |
| Total Liabilities | 7.64M | 7.65M | 6.51M | 7M | 6.58M |
| Total Equity | 9.07M | 7.41M | 5.66M | 9.13M | 7.48M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| ILS (ILS) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 21.32M | 1.38M | 9.36M | 14.46M | 12.17M |
| Total Liabilities | 6.48M | 7.99M | 8.7M | 7.05M | 6.51M |
| Total Equity | 14.84M | -6.61M | 657k | 7.41M | 5.66M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| ILS (ILS) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -3.32M | -4.64M | -7.86M | -1.43M | -3.44M |
| Investing | -457k | -456k | 2.19M | -4.47M | -1.31M |
| Financing | 5.67M | 5.4M | 5.22M | 5.33M | 5.2M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| ILS (ILS) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -20.34M | -1.34M | -5.72M | -8.48M | -7.86M |
| Investing | -108k | -125k | -625k | -10.15M | 2.19M |
| Financing | 21.87M | 1.79M | 13.5M | 14.01M | 5.22M |
| Market Cap | 2.28M |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 3.98M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.04 (6.48%) |
| Company Name | Quoin Pharmaceuticals Ltd |
| Address |
23 hata’as street kfar saba, center 44425 |
| Website | https://www.cellect.co |
| Industry | cmp programming,data process (7370) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
